Halozyme Therapeutics shares owned by Chase Investment Counsel Corp.
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Chase Investment Counsel Corp.
from 13F filings
Historical chart of Chase Investment Counsel Corp. investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Chase Investment Counsel Corp. consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Chase Investment Counsel Corp.
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.9M | 26k | 73.31 |
| 2025-06-30 | $1.4M | 26k | 52.00 |
| 2025-03-31 | $1.7M | 26k | 63.81 |
| 2024-12-31 | $1.3M | 27k | 47.81 |
| 2024-09-30 | $5.4M | 94k | 57.23 |
| 2024-06-30 | $4.8M | 91k | 52.36 |
More positions owned by Chase Investment Counsel Corp.
View all positions for Chase Investment Counsel Corp.